2020/04/30
Company:CYBERDYNE Inc.

Name ofRepresentative:

Yoshiyuki Sankai,President and CEO

Code:

7779 (Mothers Section of the Tokyo
Stock Exchange)

Contact:

Shinji Uga, Director and CFO(Tel. +81-29-869-9981)

HAL Lower Limb Type obtained medical device approval for Indonesia~ Approved for wide range of diseases in the 4th most populated nation ~CYBERDYNE Inc. [Tsukuba, Ibaraki, CEO: Yoshiyuki Sankai (the “Company”)] obtained a medical device
approval to manufacture and sell HAL for Medical Use Lower Limb Type, a device designed to improve thephysical function of the wearer, from the Ministry of Health Republic of Indonesia (Kementerian Kesehatan
Republik Indonesia), to be referred to as the “Ministry of Health”. Alike the approval that the Company
obtained in Europe, Saudi Arabia, Malaysia and Thailand, the approval that the Company obtained on thisoccasion allows HAL to be used on a wide variety of diseases such as cerebrovascular disorder, spinal cord
injury and Neuromuscular disease and etc. Following the approval, the Company can now offer Cybernics
Treatment through its Medical HAL to Indonesia, which is known to be the 4th most populated nation in theworld.

Cybernics Treatment with Medical HAL at Neuro Robotics Rehabilitation and Cybernics Centre(within SOCSO Tun Razak Rehabilitation Centre, Melaka, Malaysia)

The Company started offering Cybernics Treatment with Medical HAL in October 2018 in Malaysia as thefirst nation in the Asia Pacific after Japan. Since then, the Company has been in communication with thegovernments, medical institutions and potential distributors in the Asia Pacific to prepare the installation ofHAL. The Company regards Indonesia as one of the important medical device markets in the Asia Pacific,with the nation holding the largest number of populations in the region (4th in the world).

After the presentation in Indonesia
Left: CEO of Pusat Rehabilitasi PERKESO Sdn.
Bhd: Dr. Hafez bin Hussain
Right: BPJS Director: Krisna Syarif

Reception at the seminar event hosted by BPJS

To install Medical HAL in Indonesia, the Company coordinated with the partner in Malaysia, PUSATREHABILITASI PERKESO SDN. BHD (Kuala Lumpur, Malaysia, CEO: Dr. Hafez Bin Hussain) on theapplication for medical device approval, promotion of the technology towards medical facilities and publicinsurers. In an event hosted by Badan Penyelenggara Jaminan Sosial Ketenagakerjaan (“BPJSKetenagakerjaan”), a labor and social security agency responsible for industrial compensation, death
insurance, pension and old-age security, Dr Hafez gave a presentation on HAL and demonstrated the HAL
applications to participants from BPJS, medical institutions and engineers.
As a result, the Company succeeded in receiving approval for its Medical HAL for treating cerebrovasculardisorder, spinal cord injury and 8 types of slowly progressive rare neuromuscular disease from the Ministryof Health. Following this approval, the Company now proceeds to obtain medical approvals for HAL Single
Joint Type and HAL Lumbar Type.
Furthermore, through the coordinated effort with PERKESO, the Company have signed a contract with
one of the largest public hospitals in Indonesia on the installation of Medical HAL and have also completed
the training course, for the staff to operate the devices. However, due to the large-scale social restriction thathas been initiated as a countermeasure to the spreading of COVID-19, the delay in shipment of the product isexpected to be unavoidable. The Company will keep a close watch on the effects of the COVID-19 pandemic
and work to deliver each product as soon as possible.
The Company seeks to offer Cybernics Treatment, an innovative medical technology originated in Japan,
to Indonesia with the aim of realizing a healthy and longevity society in which all people can enjoy healthy
and prosperous lives.

A testee in demonstration explaining
to others about his experience

Members related to BPJS, medical institutions andengineers who gathered to BPJS hosted seminar

Link
HAL Lower Limb Type obtained medical device approval from the Thai FDA
https://www.cyberdyne.jp/wp_uploads/2020/04/20200413_PR_ENG.pdf
HAL Lower Limb Type obtained medical device approval from the Malaysian MDA
https://www.cyberdyne.jp/wp_uploads/2019/10/20191015_PR_MDAML_ENG.pdf“Neuro-Robotics Rehabilitation and Cybernics Center” established in Malaysia
https://www.cyberdyne.jp/wp_uploads/2019/05/20190516_PR_ENG.pdf
Start of Cybernics Treatment in Asia Pacific region
https://www.cyberdyne.jp/wp_uploads/2018/10/181016_NEWS_APAC_ENG.pdf

CYBERDYNE Inc.
URL
https://www.cyberdyne.jp/english/
FoundedJune 2004
Share capital
26.778 billion Japanese yen (as of March 31, 2020 : non-consolidated, Japanese GAAP)
CEOPresident and CEO Yoshiyuki SankaiAddress
2-2-1 Gakuen-minami, Tsukuba, Ibaraki, JapanThe Group’s business is to realize “Society 5.0/5.1”, a future society based on the idea of Techno-Peer-Support
where human and technology live together and support each other. This goal is attained through revolutionarychanges in industry and society, and The Group seeks to utilize “Cybernics Technology” (fusion andcombination of systems of human, robot and information) that handles “human” + Cyberspace” + “Physicalspace”, to create a “Cybernics Industry” for this transition following the breakthroughs of the Robotics Industryand IT Industry.